Ying Luo, CEO of Gyre Therapeutics GYRE, has filed 0 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $82.9K. The latest trade was on 06/08.

Ying Luo

CEO

Company: Gyre Therapeutics GYRE
First filing: 23/11/01

Trades: 8 trades
Buys / sales: 0 / 2
12-month net buying: −$82.9K
Last trade: 06/08

Trading activity

Transactions

	Trade type
GYRE	Open-market sale10b5-1 plan	05/05–05/06	05/07	10,315 sh2 trades	$8.04avg.	$82,927.23	−0.4%